The present document contains recommendations for assessment, prevention and treatment of cardiovascular risk for HIV-infected patients. All recommendations were graded according to the strength and quality of the evidence and were voted on by 73 members of the Italian Cardiovascular Risk Guidelines Working Group which includes both experts in HIV/AIDS care and in cardiovascular and metabolic medicine. Since antiretroviral drug exposure represents only one risk factor, continued emphasis on an integrated management is given. This should include prevention and treatment of known cardiovascular risk factors (such as dyslipidaemia, diabetes, insulin resistance, healthy diet, physical activity, avoidance of smoking), but also rational switch of...
Although AIDS/HIV infection and related deaths have significantly decreased in Italy in recent years...
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor, and the ...
none2noComment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-posit...
The present document contains recommendations for assessment, prevention and treatment of cardiovasc...
The present document contains recommendations for assessment, prevention and treatment of cardiovasc...
Abstract Background Aim of this review is to focus the attention on people living with HIV infection...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
The evaluation of cardiovascular risk in patients with HIV hinges upon a complex interplay of direct...
In HIV infected patients an increased incidence of cardiac events has been reported since the introd...
Background: Metabolic diseases are frequently observed in HIV-infected persons and, as the risk of c...
Background We aimed to identify the prevalence of cardiovascular risk factors, and investigate preve...
With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive pati...
In countries where it is available, highly active antiretroviral therapy (HAART) has transformed HIV...
BackgroundHIV patients are at increased cardiovascular risk while available European cardiovascular ...
The number of people that live with HIV continue to increase due to ample access to antiretroviral t...
Although AIDS/HIV infection and related deaths have significantly decreased in Italy in recent years...
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor, and the ...
none2noComment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-posit...
The present document contains recommendations for assessment, prevention and treatment of cardiovasc...
The present document contains recommendations for assessment, prevention and treatment of cardiovasc...
Abstract Background Aim of this review is to focus the attention on people living with HIV infection...
The objective proposed by various health authorities for the year 2010 is to reduce CHD deaths to no...
The evaluation of cardiovascular risk in patients with HIV hinges upon a complex interplay of direct...
In HIV infected patients an increased incidence of cardiac events has been reported since the introd...
Background: Metabolic diseases are frequently observed in HIV-infected persons and, as the risk of c...
Background We aimed to identify the prevalence of cardiovascular risk factors, and investigate preve...
With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive pati...
In countries where it is available, highly active antiretroviral therapy (HAART) has transformed HIV...
BackgroundHIV patients are at increased cardiovascular risk while available European cardiovascular ...
The number of people that live with HIV continue to increase due to ample access to antiretroviral t...
Although AIDS/HIV infection and related deaths have significantly decreased in Italy in recent years...
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor, and the ...
none2noComment on Suboptimal primary and secondary cardiovascular disease prevention in HIV-posit...